# Medibank Private (MPL.AU)

Canonical: https://gigainvestors.com/s/MPL.AU

Analysis as of: 2026-10-16T07:36:06.842Z. Financial observations: FY2016–FY2026.

Listing currency: AUD. Reporting currency: AUD.

## Verdict

A wonderful business at too high a price

Quality tests for Buy: pass (profit record: pass; earnings resilience is evidence only). Published buy qualification: no.

Share price: AUD 4.78 per share; close as of 2026-10-15.

Estimated value: low AUD 2.08 per share, central AUD 2.53 per share, high AUD 3.22 per share. Buy at or below the central value AUD 2.53 per share. Valuation as of 2026-10-16T07:36:06.842Z; scenarios are not confidence intervals.

Expected annual return: 7.8% at the stated quote. About 7.8% a year at today's price (required return 10.0%). required return 10.0% a year (10% floor; AU 10-year bond 5.2% + 4 points).

## Checklist

### understandable: pass

- Financial history: 10 years

- Profitable years in the last ten: 10

- Required profitable years: 8

- Return on common equity variation (informational): 0.11×

Chart: Net income; fiscal year observations.

- FY2017: AUD 450M

- FY2018: AUD 445M

- FY2019: AUD 459M

- FY2020: AUD 315M

- FY2021: AUD 441M

- FY2022: AUD 394M

- FY2023: AUD 511M

- FY2024: AUD 493M

- FY2025: AUD 501M

- FY2026: AUD 639M

### moat: pass

- Common book per share

- Parent-total proxy for preferred equity and common earnings

- Bank / P&C ROTE, median of available years: 23.4%

- Required median return: 10.0%

- Return uses tangible common equity: No

- Bank ROTE, second-lowest year: 20.2%

- Years with reported combined ratio: 0

Chart: Return on common equity; fiscal year observations.

- FY2017: 26.1%

- FY2018: 24.3%

- FY2019: 23.7%

- FY2020: 17.5%

- FY2021: 23.1%

- FY2022: 20.2%

- FY2023: 24.5%

- FY2024: 21.4%

- FY2025: 21.4%

- FY2026: 26.3%

### economics: pass

- Common book per share

- Parent-total proxy for preferred equity and common earnings

- Book value per share + reinvested dividends, annualized return: 24.5%

- Book return interval: 10 years

- Starting book value per share: AUD 0.57

- Ending book value per share: AUD 0.88

Chart: Annual book + dividend return; fiscal year observations.

- FY2017: 28.6%

- FY2018: 25.5%

- FY2019: 25.9%

- FY2020: 15.1%

- FY2021: 24.6%

- FY2022: 20.9%

- FY2023: 26.4%

- FY2024: 31.1%

- FY2025: 21.9%

- FY2026: 25.9%

### management: pass

- Common book per share

- Parent-total proxy for preferred equity and common earnings

- Diluted shares, 10-year annual growth: -0.0%

- Diluted shares, 5-year annual growth: 0.0%

- Share growth excluding flagged crisis recapitalisations: -0.0%

- Five-year share growth excluding flagged crisis recapitalisations: 0.0%

- Flagged crisis recapitalisations: 0

- Book created / earnings retained after dividends and buybacks: 1.25×

- Book value created per share: AUD 0.31

- Earnings retained per share after dividends and buybacks: AUD 0.25

Chart: Shares (first year = 100); fiscal year observations.

- FY2016: 100

- FY2017: 100

- FY2018: 100

- FY2019: 100

- FY2020: 100

- FY2021: 100

- FY2022: 100

- FY2023: 100

- FY2024: 100

- FY2025: 100

- FY2026: 100

### accounting: pass

- Financial accounting warning count: 0

- Known restatement years: 0

## Holders

## Price story

The price is 1.4 times annual sales · net income +27.5%

Story as of 2026-10-16T10:00:06.845Z; price observation 2026-10-15.

The price is 1.4 times annual sales

### Net income · FY2026

net income +27.5%; source https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/; observed 2026-10-16.

- FY2017: AUD 450M 

- FY2018: AUD 445M 

- FY2019: AUD 459M 

- FY2020: AUD 315M 

- FY2021: AUD 441M 

- FY2022: AUD 394M 

- FY2023: AUD 511M 

- FY2024: AUD 493M 

- FY2025: AUD 501M 

- FY2026: AUD 639M 

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in insurance specialty; annual sales are AUD 9.3 billion.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:36:06.842Z); FY2026: revenue 9325800000.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); MPL.AU: Medibank Private Limited provides private health insurance in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services comprising dental, optical, and physiotherapy, as well as offers health insurance products to overseas visitors and students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth and primary care services to government and corporate customers; and distributes travel, life, and pet insurance products; It underwrites and distributes private health insurance policies under the Medibank and ahm brands for resident and nonresident customers, broader community with wellbeing, prevention, primary care and homecare, with investments in short stay surgical and mental health facilities. The company was founded in 1976 and is based in Docklands, Australia.

### Why customers stay

It earns 23.4% on shareholders’ money, excluding intangible assets.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:36:06.842Z); 10-year return on tangible equity observations [[2017,0.2613676008838237],[2018,0.2433304176689263],[2019,0.23700527022837656],[2020,0.175214150628546],[2021,0.2314673941556057],[2022,0.20245682565789475],[2023,0.24520245634235271],[2024,0.21360107559526392],[2025,0.2143927394152147],[2026,0.26276381289340517]]; median 0.23423633219199114. ROIC follows the displayed moat series; financial companies use return on tangible equity.

### Where the cash goes

Paid dividends in 10 of 10 years; bought back AUD 10.7 million of shares.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:36:06.842Z); Dividend observations: [[2017,309800000],[2018,337400000],[2019,355300000],[2020,429600000],[2021,333200000],[2022,358000000],[2023,374500000],[2024,426900000],[2025,473700000],[2026,509500000]]. Zero only counted when supported by a complete cash-flow statement.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:36:06.842Z); FY2026: cash repurchases 10700000 AUD.

### Are managers owners

Insiders own 0.1% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); MPL.AU SharesStats.PercentInsiders = 0.148 percentage points; cache date 2026-10-16.

### What the price says

The price is 1.4 times annual sales.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:36:06.842Z); Closing price 4.78 AUD; reporting-to-trading FX 1; FY2026 annual sales per share 3.386270525956244; price multiple 1.4115824365952518. FY2026 cash earnings/share 0.24575134486769884. Closing-price date 2026-10-15.

## Monthly share-price history (AUD per share)

- 2016-10: AUD 2.58 per share

- 2016-11: AUD 2.60 per share

- 2016-12: AUD 2.82 per share

- 2017-01: AUD 2.70 per share

- 2017-02: AUD 2.82 per share

- 2017-03: AUD 2.82 per share

- 2017-04: AUD 2.91 per share

- 2017-05: AUD 2.75 per share

- 2017-06: AUD 2.80 per share

- 2017-07: AUD 2.72 per share

- 2017-08: AUD 3.04 per share

- 2017-09: AUD 2.92 per share

- 2017-10: AUD 3.07 per share

- 2017-11: AUD 3.27 per share

- 2017-12: AUD 3.29 per share

- 2018-01: AUD 3.35 per share

- 2018-02: AUD 3.17 per share

- 2018-03: AUD 2.90 per share

- 2018-04: AUD 2.93 per share

- 2018-05: AUD 2.93 per share

- 2018-06: AUD 2.92 per share

- 2018-07: AUD 3.11 per share

- 2018-08: AUD 3.04 per share

- 2018-09: AUD 2.91 per share

- 2018-10: AUD 2.79 per share

- 2018-11: AUD 2.42 per share

- 2018-12: AUD 2.57 per share

- 2019-01: AUD 2.62 per share

- 2019-02: AUD 2.84 per share

- 2019-03: AUD 2.76 per share

- 2019-04: AUD 2.86 per share

- 2019-05: AUD 3.31 per share

- 2019-06: AUD 3.49 per share

- 2019-07: AUD 3.61 per share

- 2019-08: AUD 3.64 per share

- 2019-09: AUD 3.40 per share

- 2019-10: AUD 3.38 per share

- 2019-11: AUD 3.26 per share

- 2019-12: AUD 3.16 per share

- 2020-01: AUD 3.10 per share

- 2020-02: AUD 2.83 per share

- 2020-03: AUD 2.66 per share

- 2020-04: AUD 2.70 per share

- 2020-05: AUD 2.85 per share

- 2020-06: AUD 2.99 per share

- 2020-07: AUD 2.82 per share

- 2020-08: AUD 2.73 per share

- 2020-09: AUD 2.51 per share

- 2020-10: AUD 2.67 per share

- 2020-11: AUD 2.85 per share

- 2020-12: AUD 3.01 per share

- 2021-01: AUD 2.92 per share

- 2021-02: AUD 2.77 per share

- 2021-03: AUD 2.80 per share

- 2021-04: AUD 3.08 per share

- 2021-05: AUD 3.13 per share

- 2021-06: AUD 3.16 per share

- 2021-07: AUD 3.31 per share

- 2021-08: AUD 3.55 per share

- 2021-09: AUD 3.59 per share

- 2021-10: AUD 3.32 per share

- 2021-11: AUD 3.45 per share

- 2021-12: AUD 3.35 per share

- 2022-01: AUD 3.09 per share

- 2022-02: AUD 3.18 per share

- 2022-03: AUD 3.08 per share

- 2022-04: AUD 3.20 per share

- 2022-05: AUD 3.22 per share

- 2022-06: AUD 3.25 per share

- 2022-07: AUD 3.41 per share

- 2022-08: AUD 3.71 per share

- 2022-09: AUD 3.47 per share

- 2022-10: AUD 2.81 per share

- 2022-11: AUD 2.93 per share

- 2022-12: AUD 2.95 per share

- 2023-01: AUD 2.94 per share

- 2023-02: AUD 3.34 per share

- 2023-03: AUD 3.36 per share

- 2023-04: AUD 3.56 per share

- 2023-05: AUD 3.57 per share

- 2023-06: AUD 3.52 per share

- 2023-07: AUD 3.51 per share

- 2023-08: AUD 3.66 per share

- 2023-09: AUD 3.44 per share

- 2023-10: AUD 3.43 per share

- 2023-11: AUD 3.46 per share

- 2023-12: AUD 3.56 per share

- 2024-01: AUD 3.84 per share

- 2024-02: AUD 3.59 per share

- 2024-03: AUD 3.76 per share

- 2024-04: AUD 3.56 per share

- 2024-05: AUD 3.72 per share

- 2024-06: AUD 3.73 per share

- 2024-07: AUD 3.98 per share

- 2024-08: AUD 3.86 per share

- 2024-09: AUD 3.65 per share

- 2024-10: AUD 3.59 per share

- 2024-11: AUD 3.82 per share

- 2024-12: AUD 3.79 per share

- 2025-01: AUD 4.00 per share

- 2025-02: AUD 4.35 per share

- 2025-03: AUD 4.44 per share

- 2025-04: AUD 4.65 per share

- 2025-05: AUD 4.77 per share

- 2025-06: AUD 5.05 per share

- 2025-07: AUD 5.10 per share

- 2025-08: AUD 5.10 per share

- 2025-09: AUD 4.82 per share

- 2025-10: AUD 4.88 per share

- 2025-11: AUD 4.75 per share

- 2025-12: AUD 4.79 per share

- 2026-01: AUD 4.62 per share

- 2026-02: AUD 4.38 per share

- 2026-03: AUD 4.36 per share

- 2026-04: AUD 4.69 per share

- 2026-05: AUD 4.80 per share

- 2026-06: AUD 4.97 per share

- 2026-07: AUD 5.17 per share

- 2026-08: AUD 4.84 per share

- 2026-09: AUD 4.62 per share

- 2026-10: AUD 4.68 per share

## Annual estimated value (AUD per share)

- FY2017: low AUD 1.52 per share, central AUD 1.90 per share, high AUD 2.53 per share

- FY2018: low AUD 1.14 per share, central AUD 1.26 per share, high AUD 1.40 per share

- FY2019: low AUD 1.20 per share, central AUD 1.32 per share, high AUD 1.46 per share

- FY2020: low AUD 1.01 per share, central AUD 1.12 per share, high AUD 1.24 per share

- FY2021: low AUD 1.58 per share, central AUD 1.97 per share, high AUD 2.63 per share

- FY2022: low AUD 1.65 per share, central AUD 2.05 per share, high AUD 2.69 per share

- FY2023: low AUD 1.82 per share, central AUD 2.25 per share, high AUD 2.97 per share

- FY2024: low AUD 2.15 per share, central AUD 2.67 per share, high AUD 3.52 per share

- FY2025: low AUD 2.15 per share, central AUD 2.67 per share, high AUD 3.51 per share

- FY2026: low AUD 2.08 per share, central AUD 2.53 per share, high AUD 3.22 per share

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.

## Reported holder observations